Nerve growth factor receptor limits inflammation to promote remodeling and repair of osteoarthritic joints

Area of Science:

• Skeletal biology
• Immunology
• Osteoarthritis research

Background:

• Osteoarthritis (OA) affects over 500 million people globally, presenting as a painful, incurable joint disease.
• Recent studies on nerve growth factor (NGF) inhibitors in OA patients indicate potential adverse effects on joint structure.
• The role of nerve growth factor receptor (NGFR) in the pathogenesis and repair of OA remains largely unexplored.

Purpose of the Study:

• To investigate the role of nerve growth factor receptor (NGFR) in the skeletal remodeling and repair processes during osteoarthritis.
• To elucidate the molecular mechanisms by which NGFR influences cellular signaling pathways involved in OA.
• To determine the association between NGFR expression and inflammatory markers in human OA cartilage.

Main Methods:

• Analysis of NGFR expression in skeletal cells during osteoarthritis.
• Investigating the effect of NGFR deficiency on bone remodeling and resorption in murine OA models.
• Examining the impact of TNFα-induced NGFR on NF-κB and BMP-SMAD1 signaling pathways.
• Assessing the correlation between NGFR and NF-κB activation in human OA cartilage samples.

Main Results:

• Nerve growth factor receptor (NGFR) is upregulated in osteochondral cells during OA, but not in skeletal progenitor cells.
• NGFR expression, induced by TNFα, attenuates NF-κB activation and maintains BMP-SMAD1 signaling while suppressing RANKL expression.
• NGFR deficiency leads to hyper-activation of NF-κB in murine OA joints, resulting in impaired bone formation and increased bone resorption.
• A reduction in subchondral bone and osteophytes was observed in NGFR-deficient OA mice.
• Human OA cartilage shows a negative association between NGFR expression and NF-κB activation.

Conclusions:

• Nerve growth factor receptor (NGFR) plays a critical role in the remodeling and repair of osteoarthritic joints.
• NGFR functions by limiting inflammation through the suppression of NF-κB activation, thereby promoting skeletal repair.
• Targeting NGFR may offer a novel therapeutic strategy for managing osteoarthritis and related skeletal disorders.